n.a. (MEDS)

0.00
NASDAQOTCBB
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.55 / 2.80
Exchange NASDAQOTCBB
Market Cap 18.50M
Div & Yield N.A. (N.A)

Medistem Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Intrexon

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Medistem,...

Intrexon To Acquire Medistem To Generate Multipotent Cells

Medistem's Stem Cell Technology to be Integrated Into Intrexon's Proprietary Synthetic Biology Platform

Intrexon To Acquire Medistem To Generate Multipotent Cells

Medistem's Stem Cell Technology to be Integrated into Intrexon's Proprietary Synthetic Biology Platform

Medistem CEO Dr. Alan Lewis To Present At The Stem Cell Meeting On The Mesa

Medistem announced today Dr. Alan Lewis, the recently appointed CEO of Medistem, will be presenting at the Stem Cells on the Mesa meeting.

NIH Data Suggests Medistem’s Stem Cell Is Unique From Competitor Stem Cells

Medistem Inc. (PINKSHEETS:  MEDS) announced today a peer-reviewed publication led by NIH scientists demonstrating that the company’s Endometrial Regenerative Cells (ERC) possess a unique genetic signature...

Biopharmaceutical Executive Dr. Alan Lewis Appointed As CEO Of Medistem

Medistem Inc. (PINKSHEETS:  MEDS) announced today appointment of Dr.

Medistem And Superview Biotechnology Co. Ltd. Initiate Collaboration On Therapeutics Development Using Antibody And Stem Cell Technology

Medistem Inc (Pink Sheets:MEDS) announced today the initiation of a collaboration with Superview Biotechnology Co.

Medistem Discussing ERC Stem Cells

Medistem Inc (Pink Sheets:MEDS), a clinical stage adult stem cell company, today announced that its CEO Dr.